ADIL Adial Pharmaceuticals, Inc.: Net earnings per share for the last 12 months

Public company logo of Adial Pharmaceuticals Inc. (ADIL)

The annual EPS (TTM) growth rate, based on GURU.Markets data, clearly demonstrates trends where the 46.30 metric determines this level. Adial Pharmaceuticals (ADIL) leverages its authority in addiction therapy through the safe drug AD04. Final-stage testing and expansion into Europe are driving growth. A patent shield and FDA certification costs ensure the company's exclusive dominance.

ADIL Adial Pharmaceuticals Inc. Net earnings per share (EPS TTM) (02/11/2024 - 10/29/2026)

Adial Pharmaceuticals - analytical breakdowns and key metrics (ADIL)

- company stock capitalization data:
Initial company analysis:Adial Pharmaceuticals - ADIL
Original product of Adial

For Adial Pharmaceuticals (ADIL), the year-over-year (TTM) EPS comparison serves as a tool for monitoring capitalization efficiency. This metric measures the percentage change in net income per share over a rolling year. The calculation is based on the difference between the current and previous periods, identifying growth or decline rates in profitability. For a company in the drug development stage, this is a critical marker of the absence of stable cash flow. Any slowdown in this trend signals an increase in business risks.

Direct competitors

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|India Globalization Capital - Earnings per share for the trailing year|Earnings per share for the last twelve months MIRA Pharma|FLGC: Earnings per share for the trailing year|Earnings per share for the last twelve months IMC (IMCC)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO